Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase II multicentre multinational study. Exemestane Study Group.
暂无分享,去创建一个
R. Paridaens | J. Bonneterre | B. Thürlimann | D. Serin | S. Lanzalone | H. Roché | E. di Salle | G. Piscitelli | R. Murray | M. Zurlo